Ardavan M. Khoshnood

Dr. Ardavan M. Khoshnood

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in JACC
Verified
Journal Article
Closed access
AMArash Mokhtari
Arash Mokhtari
CBCatharina Borna
Catharina Borna
PGPatrik Gilje
Patrik Gilje
PTPatrik Tydén
Patrik Tydén
BLBertil Lindahl
Bertil Lindahl
UEUlf Ekelund
Ulf Ekelund

19 March 2021 in Journal of Policing, Intelligence and Counter Terrorism
Verified
Journal Article
Open access
MGManne Gerell
Manne Gerell
JSJoakim Sturup
Joakim Sturup
MMMia-Maria Magnusson
Mia-Maria Magnusson
KNKim Nilvall
Kim Nilvall
AKArdavan M. Khoshnood
Ardavan M. Khoshnood
ARAmir Rostami
Amir Rostami
Gun violence is a serious issue in many countries across the globe. It has been shown that there is an elevated risk for a further shooting nearby within a short time span of a shooting incident, so-called near-repeat patterning. The present study presents new evidence on near-repeat patterning in Sweden, with a focus on neighbourhoods which the police have labelled as ‘vulnerable’ – deprived neighbourhoods where criminal networks have a large impact on local communities. Such neighbourhoods tend to have open drug markets, and to have high levels of gun violence. The present paper analyses the association of open drug markets and vulnerable neighbourhoods with gun violence and near-repeat patterning of gun violence in two Swedish cities. Our findings suggest that gun violence is strongly concentrated on open drug markets in vulnerable neighbourhoods, and that those locations in addition exhibit high risks for repeat shootings after an initial shooting event. We propose that the police can use this knowledge to improve practices to prevent or disrupt gun violence.

1 December 2016 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
AMArash Mokhtari
Arash Mokhtari
BLBertil Lindahl
Bertil Lindahl
JSJ. Gustav Smith
J. Gustav Smith
MHMartin J. Holzmann
Martin J. Holzmann
AKArdavan M. Khoshnood
Ardavan M. Khoshnood
UEUlf Ekelund
Ulf Ekelund

1 April 2018 in European Journal of Emergency Medicine
Verified
Journal Article
Closed access
PDF file
AKArdavan M. Khoshnood
Ardavan M. Khoshnood
MCMarcus Carlsson
Marcus Carlsson
MAMahin Akbarzadeh
Mahin Akbarzadeh
PBPallonji Bhiladvala
Pallonji Bhiladvala
ARAnders Roijer
Anders Roijer
UEUlf Ekelund
Ulf Ekelund
Objective: Recent studies suggest that administration of O2 in patients with acute myocardial infarction may have negative effects. With the use of cardiac MRI (CMR), we evaluated the effects of supplemental O2 in patients with ST elevation myocardial infarction (STEMI) accepted for acute percutaneous coronary intervention (PCI). Materials and methods: This study was a randomized-controlled trial conducted at two university hospitals in Sweden. Normoxic STEMI patients were randomized in the ambulance to either supplemental O2 (10 l/min) or room air until the conclusion of the PCI. CMR was performed 2–6 days after the inclusion. The primary endpoint was the myocardial salvage index assessed by CMR. The secondary endpoints included infarct size and myocardium at risk. Results: At inclusion, the O2 (n=46) and air (n=49) patient groups had similar patient characteristics. There were no significant differences in myocardial salvage index [53.9±25.1 vs. 49.3±24.0%; 95% confidence interval (CI): −5.4 to 14.6], myocardium at risk (31.9±10.0% of the left ventricle in the O2 group vs. 30.0±11.8% in the air group; 95% CI: −2.6 to 6.3), or infarct size (15.6±10.4% of the left ventricle vs. 16.0±11.0%; 95% CI: −4.7 to 4.1). Conclusion: In STEMI patients undergoing acute PCI, we found no effect of high-flow oxygen compared with room air on the size of ischemia before PCI, myocardial salvage, or the resulting infarct size. These results support the safety of withholding supplemental oxygen in normoxic STEMI patients.

8 August 2012 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
UEUlf Ekelund
Ulf Ekelund
MAMahin Akbarzadeh
Mahin Akbarzadeh
AKArdavan M. Khoshnood
Ardavan M. Khoshnood
JBJonas Björk
Jonas Björk
MOMattias Ohlsson
Mattias Ohlsson
There is a circadian and circaseptal (weekly) variation in the onset of acute coronary syndrome (ACS). The aim of this study was to elucidate whether the likelihood of ACS among emergency department (ED) chest pain patients varies with the time of presentation.

13 May 2017 in Academic Emergency Medicine
Verified
Journal Article
Open access
PDF file
AMArash Mokhtari
Arash Mokhtari
BLBertil Lindahl
Bertil Lindahl
ASAlexandru Schiopu
Alexandru Schiopu
TYTroels Yndigegn
Troels Yndigegn
AKArdavan M. Khoshnood
Ardavan M. Khoshnood
UEUlf Ekelund
Ulf Ekelund
Objectives: Guidelines recommend a 0‐hour/1‐hour high‐sensitivity cardiac troponin T (hs‐cTnT) diagnostic strategy in acute chest pain patients. There are, however, little data on the performance of this strategy when combined with clinical risk stratification. We aimed to evaluate the diagnostic accuracy of an accelerated diagnostic protocol (ADP) using the 0‐hour/1‐hour hs‐cTnT strategy together with an adapted Thrombolysis In Myocardial Infarction (TIMI) score and electrocardiogram (ECG) for ruling out major adverse cardiac events (MACE) within 30 days.Methods: This prospective observational study enrolled consecutive emergency department (ED) chest pain patients. TIMI score variables, ED physicians’ assessments of the ECG, and 0‐ and 1‐hour hs‐cTnT were collected. Thirty‐day MACE was defined as acute myocardial infarction (AMI), unstable angina (UA), cardiogenic shock, ventricular arrhythmia, atrioventricular block, cardiac arrest, or death of cardiac or unknown cause.Results: A total of 1,020 patients were included in the final analysis. The combination of an adapted TIMI score ≤1, a nonischemic ECG, and either a 0‐hour hs‐cTnT < 5 ng/L or a 0‐hour hs‐cTnT < 12 ng/L combined with a 1‐hour increase < 3 ng/L identified 432 (42.4%) patients as very low risk with a negative predictive value of 99.5% (95% confidence interval [CI] = 98.3%–99.9%) and a negative likelihood ratio of 0.04 (95% CI = 0.01–0.14) for 30‐day MACE. The ADP missed only two patients with UA and no patients with AMI or other forms of MACE.Conclusion: An ADP using the guideline recommended 0‐hour/1‐hour hs‐cTnT strategy rapidly identified patients with a very low risk of 30‐day MACE including UA where no further cardiac testing would be needed. This could potentially allow safe early discharge of about 40% of ED chest pain patients.